ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA announces expansion of generic impurity investigation
September 02, 2019The examination of ARB drugs by the FDA will be extended to include other generics with similar manufacturing processes to identify impurities. -
Impurity in valsartan leads to voluntary recall
August 07, 2018Healthcare professionals and patients have been alerted by the U.S. Food and Drug Administration (FDA) of a voluntary recall of drugs containing the active ingredient valsartan. This active ingredient is used in drugs to treat high blood pressure and hear
Pharma Sources Insight January 2025
